| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 10 | +50.00% | +2.39% | -1.00% | +3.39% | +2.25% | — |
| 14d | 10 | +60.00% | +2.59% | -1.61% | +4.21% | +0.88% | — |
| 30d | 10 | +40.00% | -1.11% | -3.78% | +3.03% | -1.93% | — |
| 60d | 10 | +20.00% | -2.13% | +0.23% | -2.36% | -8.02% | — |
| 90d | 10(1 pending) | +0.00% | -9.66% | +0.81% | -10.47% | -5.72% | — |
| 180d | 10(1 pending) | +22.22% | -19.19% | -0.09% | -19.10% | -36.11% | — |
| 1y | 10(1 pending) | +55.56% | -0.13% | +8.15% | -8.28% | -1.21% | — |
| 2y | 10(2 pending) | +0.00% | -41.73% | +33.55% | -75.28% | -84.14% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| TVTX TRAVERE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 4,000 | — | — | 91,500 | May 19, 2026 | May 21, 2026 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 12,000 | — | — | 12,000 | May 19, 2026 | May 21, 2026 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 8,000 | $45.00 | $360.0K | 87,500 | May 4, 2026 | May 6, 2026 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | SALE | 8,000 | — | — | 0 | May 4, 2026 | May 6, 2026 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | PURCHASE | 8,000 | $16.33 | $130.6K | 95,500 | May 4, 2026 | May 6, 2026 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | SALE Co-Chief Executive Officer | 3,033 | — | — | 0 | Feb 11, 2026 | Feb 13, 2026 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | SALE Co-Chief Executive Officer | 12,136 | — | — | 0 | Feb 11, 2026 | Feb 13, 2026 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 12,136 | — | — | 12,136 | Feb 11, 2026 | Feb 13, 2026 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 3,033 | — | — | 3,033 | Feb 11, 2026 | Feb 13, 2026 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | SALE Co-Chief Executive Officer | 1,519 | — | — | 0 | Feb 11, 2026 | Feb 13, 2026 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 1,519 | — | — | 1,519 | Feb 11, 2026 | Feb 13, 2026 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 216,617 | $2.03 | $439.7K | 229,929 | Dec 22, 2025 | Dec 29, 2025 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 6,068 | $8.30 | $50.4K | 13,312 | Jul 27, 2025 | Jul 29, 2025 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 12,136 | $8.30 | $100.8K | 16,688 | Jul 27, 2025 | Jul 29, 2025 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 6,500 | — | — | 87,500 | May 15, 2025 | May 16, 2025 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 19,500 | — | — | 19,500 | May 15, 2025 | May 16, 2025 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | SALE Chief Executive Officer | 1,250 | $0.04 | $46 | 0 | Apr 10, 2025 | Apr 11, 2025 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | SALE Chief Executive Officer | 3,750 | $0.04 | $139 | 0 | Apr 10, 2025 | Apr 11, 2025 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | SALE Chief Executive Officer | 813 | $0.04 | $30 | 0 | Apr 10, 2025 | Apr 11, 2025 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | SALE Chief Executive Officer | 1,563 | $0.04 | $58 | 0 | Apr 10, 2025 | Apr 11, 2025 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | SALE Chief Executive Officer | 4,750 | $0.04 | $176 | 0 | Apr 10, 2025 | Apr 11, 2025 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | SALE Chief Executive Officer | 1,500 | $0.04 | $56 | 0 | Apr 10, 2025 | Apr 11, 2025 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 42,553 | $1.18 | $50.0K | 42,553 | Nov 25, 2024 | Nov 26, 2024 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 42,553 | $1.18 | $50.0K | 202,859 | Nov 25, 2024 | Nov 26, 2024 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | PURCHASE | 40,000 | $10.48 | $419.2K | 121,000 | Sep 30, 2024 | Sep 30, 2024 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 40,000 | $14.06 | $562.3K | 81,000 | Sep 30, 2024 | Sep 30, 2024 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | PURCHASE | 40,000 | — | — | 0 | Sep 30, 2024 | Sep 30, 2024 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 84,932 | $1.83 | $155.0K | 84,932 | Aug 8, 2024 | Aug 8, 2024 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 84,932 | $1.83 | $155.0K | 160,306 | Aug 8, 2024 | Aug 8, 2024 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 19,500 | — | — | 19,500 | May 8, 2024 | May 10, 2024 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 6,500 | — | — | 81,000 | May 8, 2024 | May 10, 2024 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Jan 22, 2024 | Jan 23, 2024 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 13,500 | — | — | 13,500 | May 17, 2023 | May 19, 2023 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 4,500 | — | — | 74,500 | May 17, 2023 | May 19, 2023 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Jan 18, 2023 | Jan 20, 2023 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | PURCHASE CEO and Director | 9,600 | $1.90 | $18.2K | 75,374 | Nov 21, 2022 | Nov 22, 2022 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | PURCHASE CEO and Director | 400 | $1.76 | $705 | 65,774 | Nov 18, 2022 | Nov 22, 2022 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | PURCHASE CEO and Director | 10,308 | $2.80 | $28.9K | 65,374 | Sep 8, 2022 | Sep 12, 2022 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | PURCHASE CEO and Director | 8,632 | $2.57 | $22.2K | 55,066 | Sep 7, 2022 | Sep 8, 2022 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | PURCHASE CEO and Director | 1,060 | $2.44 | $2.6K | 46,434 | Sep 6, 2022 | Sep 8, 2022 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | PURCHASE CEO and Director | 19,727 | $2.63 | $51.9K | 45,374 | Jun 6, 2022 | Jun 7, 2022 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 9,000 | — | — | 9,000 | May 11, 2022 | May 12, 2022 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 3,000 | — | — | 70,000 | May 11, 2022 | May 12, 2022 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 200,000 | — | — | 200,000 | Jan 26, 2022 | Jan 28, 2022 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | PURCHASE CEO and Director | 11,187 | $5.82 | $65.1K | 25,647 | Nov 18, 2021 | Nov 19, 2021 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | PURCHASE CEO and Director | 12,000 | $7.00 | $84.0K | 14,460 | Sep 14, 2021 | Sep 16, 2021 ↗ | View → |
| INDP INDAPTUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 375,000 | — | — | 375,000 | Aug 4, 2021 | Aug 6, 2021 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 3,000 | — | — | 67,000 | May 14, 2021 | May 18, 2021 ↗ | View → |
| TVTX TRAVERE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 9,000 | — | — | 9,000 | May 14, 2021 | May 18, 2021 ↗ | View → |